Aurobindo Pharma Received an Approval from USFDA for Generic Cefadroxil Oral Suspension

Apr 26, 2013 15:58 IST

Aurobindo Pharma, the drug firm on 26 April 2013 announced that it received an approval from US Food & Drug Administration (USFDA), the US health regulator for manufacturing as well as marketing the generic Cefadroxil oral suspension. Generic Cefadroxil is used for the treatment of bacterial infections in US market.

Aurobindo Pharma got an approval from US Food & Drug Administration (USFDA) for manufacturing and marketing Cefadroxil in strengths of 250mg/5mL and 500mg/5mL. Cefadroxil is generic equivalent of Duricef of Warner Chilcott Company Inc. Duricef is also used for oral suspension in similar strength.

Cefadroxil oral suspension got approval out of cephalosporin formulations manufacturing facility of the company in Hyderabad.

With this, Aurobindo Pharma got a total of 187 abbreviated new drug application (ANDA) approvals from the US health regulator. This includes 4 from Aurolife Pharma LLC and 27 tentative approvals.

 

US Food and Drug Administration Lifted Import Alert on Aurobindo Pharma


Aurobindo Pharm received Approval from USFDA to Manufacture & Market Divalproex


Aurobindo Received Approval for Ondansetron

Is this article important for exams ? Yes9 People Agreed

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK